Grant Wickman
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Oncology top 10%
- HER2/EGFR in Cancer Research
Papers in
-
- Cell death mechanisms and regulation 3
- Protein Kinase Regulation and GTPase Signaling 3
- Glycosylation and Glycoproteins Research 2
- Oncology 8
- HER2/EGFR in Cancer Research 4
- Co-authors
- Michael F. Olson (7 shared papers)Linda Julian (3 shared papers)Karin Amundson (4 shared papers)Dana D. Hu‐Lowe (4 shared papers)Jeffrey H. Chen (2 shared papers)Robert S. Kania (2 shared papers)Shinji Yamazaki (1 shared paper)Bozena Vollrath (3 shared papers)
- Journals
- Cancer Research (5 papers)Cell Death and Differentiation (2 papers)Clinical Cancer Research (1 paper)Blood (1 paper)Oncogene (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Grant Wickman
20 papers receiving 1.4k citations
Grant Wickman's Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 246
- Oncology 326
- Immunology and Allergy 69
- Cell Biology 176
- Molecular Biology 693
Countries citing papers authored by Grant Wickman
This map shows the geographic impact of Grant Wickman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant Wickman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant Wickman more than expected).
Fields of papers citing papers by Grant Wickman
This network shows the impact of papers produced by Grant Wickman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant Wickman. The network helps show where Grant Wickman may publish in the future.
Co-authors
The 25 scholars most cited alongside Grant Wickman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3 Hit paper breakdown → | 2008 | 540 |
| 2 | 2012 | 196 | |
| 3 | 2013 | 161 | |
| 4 | 2010 | 146 | |
| 5 | 2003 | 83 | |
| 6 | 2010 | 76 | |
| 7 | 2018 | 40 | |
| 8 | 2010 | 31 | |
| 9 | 2017 | 31 | |
| 10 | 2010 | 21 | |
| 11 | 2021 | 17 | |
| 12 | A study on the anti-inflammatory activity of Cayaponia tayuya root. | 1990 | 14 |
| 13 | 2021 | 12 | |
| 14 | 2001 | 12 | |
| 15 | 2009 | 9 | |
| 16 | 2000 | 7 | |
| 17 | AG-028262, a novel selective VEGFR tyrosine kinase antagonist that potently inhibits KDR signaling and angiogenesis in vitro and in vivo | 2004 | 7 |
| 18 | 2016 | 6 | |
| 19 | 2020 | 3 | |
| 20 | 2025 | 1 |
About Grant Wickman
Grant Wickman is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Physiology, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (4 papers), Cell death mechanisms and regulation (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Cell Adhesion Molecules Research (3 papers), Phagocytosis and Immune Regulation (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Intracranial Aneurysms: Treatment and Complications (2 papers). The work is most often cited by research in Cancer Research (246 citations), Oncology (326 citations), Immunology and Allergy (69 citations), Cell Biology (176 citations) and Molecular Biology (693 citations). Grant Wickman has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Michael F. Olson, Linda Julian, Karin Amundson, Dana D. Hu‐Lowe, Jeffrey H. Chen, Robert S. Kania, Shinji Yamazaki, Bozena Vollrath, Max Hallin and David R. Shalinsky. Their work appears in journals such as Cancer Research, Cell Death and Differentiation, Clinical Cancer Research, Blood and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.